NLRP3 and metabolic dysfunction-associated steatotic liver disease: In mice with MASLD induced by methionine-choline deficiency and in HpeG2 cells treated with OA, naringenin reduced lipid accumulation through inhibition of the inflammatory cytokine-mediated signaling pathway NLRP3/NFkB [41].